Balyasny Asset Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15,614
| Closed | -$67.5K | – | 2529 |
|
|
2024
Q1 | $67.5K | Buy |
+15,614
| New | +$67.5K | ﹤0.01% | 1892 |
|
|
2023
Q1 | – | Sell |
-13,241
| Closed | -$71.9K | – | 2741 |
|
|
2022
Q4 | $71.9K | Buy |
+13,241
| New | +$71.9K | ﹤0.01% | 1856 |
|
|
2022
Q3 | – | Sell |
-28,394
| Closed | -$140K | – | 2830 |
|
|
2022
Q2 | $140K | Sell |
28,394
-781
| -3% | -$3.85K | ﹤0.01% | 1804 |
|
|
2022
Q1 | $222K | Buy |
+29,175
| New | +$222K | ﹤0.01% | 1644 |
|
|
2019
Q1 | – | Sell |
-15,135
| Closed | -$290K | – | 1580 |
|
|
2018
Q4 | $290K | Buy |
+15,135
| New | +$290K | ﹤0.01% | 1137 |
|
|
2018
Q3 | – | Sell |
-6,554
| Closed | -$285K | – | 1834 |
|
|
2018
Q2 | $285K | Buy |
+6,554
| New | +$285K | ﹤0.01% | 1359 |
|